Nivalis Therapeutics CEO Mitchell Gold's 2019 pay jumps 49% to $1.6M
Nivalis Therapeutics reports 2019 executive compensation
By ExecPay News
Published: May 5, 2020
Nivalis Therapeutics reported fiscal year 2019 executive compensation information on May 5, 2020.
In 2019, three executives at Nivalis Therapeutics received on average a compensation package of $1.1M, a 8% decrease compared to previous year.
Average pay of disclosed executives at Nivalis Therapeutics
Mitchell H. Gold, Chief Executive Officer, received $1.6M in total, which increased by 49% compared to 2018. 55% of Gold's compensation, or $853K, was in option awards. Gold also received $218K in non-equity incentive plan and $485K in salary.
Stanford Peng, President and Head of Research and Development, received a compensation package of $971K, which decreased by 52% compared to previous year. 46% of the compensation package, or $443K, was in salary.
Paul Rickey, Chief Financial Officer, earned $810K in 2019, a 8% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 5, 2020.